pharmaceuticals

What businesses in APAC should expect under a second Trump administration: Opportunities, challenges, and takeaways

What businesses in APAC should expect under a second Trump administration: Opportunities, challenges, and takeaways

As Americans head to the polls in an election that may well come down to the wire, now is our chance to take final stock of what the post-election future may hold for those impacted by China-U.S. relations, including the many businesses for which both markets are essential.
Sandpiper Appoints Liz Egginton to Lead Technology Practice

Sandpiper Appoints Liz Egginton to Lead Technology Practice

Based in Australia, Liz will lead the development and long-term growth of the firm’s Technology practice across Asia Pacific, integrating Sandpiper’s world-class offerings, including Content Strategy, Research and Insights, Government Affairs, Reputation Management, and International Media, to drive intentional and strategic communications outcomes for clients.
24 hours to go: What comes next for U.S.-China relations after the election?

24 hours to go: What comes next for U.S.-China relations after the election?

As Americans head to the polls in an election that may well come down to the wire, now is our chance to take final stock of what the post-election future may hold for those impacted by China-U.S. relations, including the many businesses for which both markets are essential.
Sandpiper Appoints Hermen Chow to its Financial and Professional Practices in Hong Kong

Sandpiper Appoints Hermen Chow to its Financial and Professional Practices in Hong Kong

Hermen will work alongside Sandpiper’s leadership and senior team to continue to grow the firm’s financial and professional services practices in Hong Kong and across Asia Pacific.
Genome Sequencing and Personalised Medicine

Genome Sequencing and Personalised Medicine

The advent of genome sequencing is revolutionising healthcare, including a significant paradigm shift toward personalised medicine, paving the way for tailored diagnosis, treatment and prevention.
Public Affairs Tracker: Strategies to Develop Health Policy in China

Public Affairs Tracker: Strategies for Influencing Health Policies in China

Under China's new medical reform, the government has become the largest purchaser of medicine. For pharmaceutical enterprises, favourable policies are the key to market access.